Profund Advisors’s Anavex Life Sciences AVXL Stock Holding History

Profund Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$197K	Buy	64,223 +6,251	+11%	+$27.1K	0.01%	1036
2025 Q4	$206K	Buy	57,972 +34,072	+143%	+$209K	0.01%	1145
2025 Q3	$213K	Buy	23,900 +4,047	+20%	+$41K	0.01%	946
2025 Q2	$183K	Sell	19,853 -6,767	-25%	-$57.8K	0.01%	923
2025 Q1	$228K	Buy	26,620 +11,240	+73%	+$106K	0.01%	837
2024 Q4	$165K	Sell	15,380 -12,593	-45%	-$96.9K	0.01%	1037
2024 Q3	$159K	Sell	27,973 -13,307	-32%	-$76.8K	0.01%	1077
2024 Q2	$174K	Sell	41,280 -61,758	-60%	-$250K	0.01%	1005
2024 Q1	$524K	Buy	103,038 +64,668	+169%	+$364K	0.02%	561
2023 Q4	$357K	Sell	38,370 -7,595	-17%	-$52.3K	0.02%	690
2023 Q3	$301K	Sell	45,965 -17,689	-28%	-$141K	0.02%	663
2023 Q2	$518K	Sell	63,654 -22,258	-26%	-$191K	0.03%	502
2023 Q1	$736K	Buy	+85,912	New	+$857K	0.05%	386

Other funds holding AVXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Profund Advisors's AVXL Position: Q1 2026 in Review

Profund Advisors increased its Anavex Life Sciences (AVXL) stake by 11% in Q1 2026, buying an estimated $27.1K and bringing the position to 64,223 shares worth $197K. The position accounts for 0.01% of the portfolio, ranked #1036.

Profund Advisors first reported a position in AVXL in Q1 2023 and has held it in 13 quarters since. The position peaked at $736K in Q1 2023. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

Profund Advisors held 64,223 shares of Anavex Life Sciences worth $197K as of Q1 2026.
Profund Advisors bought 6,251 Anavex Life Sciences shares in Q1 2026, an estimated $27.1K.
Anavex Life Sciences made up 0.01% of Profund Advisors's portfolio in Q1 2026, its #1036 holding.
Profund Advisors first reported a position in Anavex Life Sciences in Q1 2023 and has held it in 13 quarters since.
Profund Advisors's Anavex Life Sciences position peaked at $736K in Q1 2023.
190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.